← Eichor
Study identifier: NCT05500755 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants

Condition: Dental Implants  ·  Sponsor: Aula Dental Avanzada

PhaseN/A
Planned participants150
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA). Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met. Clinicians need to have a "real" analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.

This description comes directly from the study's public registry record.

Talk to the study team

Guillem Esteve-Pardo, PhD  ·  +34965215755  ·  guillem@clinicaesteve.com

Always discuss trial participation with your own doctor first.

Locations (1)

Clínica Dental esteveAlicante, Alicante, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05500755